Home › Companies › VIKING THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and VIKING THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 21, 2024: 6 items on VIKING THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024: 4 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VIKING THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VIKING THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Brian Lian, Ph.D. | 50,502,615 | -- | -- | 17,436,415 | 20,260,462 | 74% | Not verified | — |
| Elect Director: Lawson Macartney, Ph.D. | 22,267,255 | -- | -- | 45,671,775 | 20,260,462 | 33% | Not verified | — |
| 2. To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024 | 87,382,144 | 743,579 | 73,767 | -- | -- | 99.1% | Approved | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement | 63,234,707 | 4,510,461 | 193,862 | -- | 20,260,462 | 93% | Approved | — |
| 4. To approve the 2024 EIP | 48,547,615 | 19,279,010 | 112,405 | -- | 20,260,462 | 72% | Approved | — |
| 5. To approve the 2024 ESPP | 67,119,655 | 734,042 | 85,333 | -- | 20,260,462 | 99% | Approved | — |
Source: VIKING THERAPEUTICS INC., Form 8-K, filed with the SEC on May 23, 2024 — read the filing on EDGAR.
Each item below shows how the 372 asset managers that disclosed a VIKING THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VIKING THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Brian Lian, Ph.D.
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Brian Lian, Ph.D.”): 50,502,615 for, 17,436,415 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 25,130,078 for, 10,498,885 withheld, 147,035 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,799,363 | 0 | 0 | 10,364,868 | Mixed |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,464 | 0 | 0 | 112 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 232,360 | 0 | 0 | 82,717 | Mixed |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 236,307 | 0 | 1,934 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Combines 9 wordings of this item as funds reported it.
33% Plurality election · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Lawson Macartney, DVM, Ph.D.
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lawson Macartney, Ph.D.”): 22,267,255 for, 45,671,775 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 33% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 11,425,236 for, 30 against, 23,595,083 withheld, 755,649 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,697,041 | 0 | 0 | 10,467,190 | Mixed |
| Vanguard | 7,513,035 | 0 | 0 | 189,100 | For |
| BlackRock | 0 | 0 | 0 | 3,600,224 | Withhold |
| State Street | 1,032 | 0 | 0 | 1,046,544 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 838,984 | Withhold |
| American Century | 0 | 0 | 0 | 769,898 | Withhold |
| Voya | 0 | 0 | 0 | 611,073 | Withhold |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 568,931 | Withhold |
| TIAA | 0 | 0 | 0 | 411,560 | Withhold |
| Invesco | 0 | 0 | 0 | 351,183 | Withhold |
| Legg Mason | 0 | 0 | 0 | 345,200 | Withhold |
| Equitable | 0 | 0 | 0 | 336,330 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 336,235 | Withhold |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 0 | 0 | 316,600 | Withhold |
| Principal | 163 | 0 | 0 | 314,914 | Withhold |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 267,893 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 266,975 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 252,485 | Withhold |
| MFS | 0 | 0 | 0 | 251,577 | Withhold |
| Victory Capital | 0 | 0 | 0 | 243,208 | Withhold |
| Jackson National | 0 | 0 | 238,241 | 0 | Abstain |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.1% of fund votes cast · no official result
The 110 asset managers below reported 35,457,083 for, 312,110 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,576 | 0 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Combines 3 wordings of this item as funds reported it.
79% of fund votes cast · no official result
The 110 asset managers below reported 28,155,855 for, 7,606,377 against, 6,961 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,124,513 | 39,718 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,032 | 1,046,544 | 0 | 0 | Against |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 0 | 769,898 | 0 | 0 | Against |
| Voya | 0 | 611,073 | 0 | 0 | Against |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 0 | 411,560 | 0 | 0 | Against |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 336,235 | 0 | 0 | Against |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 316,600 | 0 | 0 | Against |
| Principal | 201,278 | 113,799 | 0 | 0 | Mixed |
| Putnam | 0 | 311,905 | 0 | 0 | Against |
| Lord Abbett | 0 | 277,398 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 16,500 | 252,969 | 0 | 0 | Mixed |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 266,975 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 252,485 | 0 | 0 | Against |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 0 | 243,208 | 0 | 0 | Against |
| Jackson National | 140,222 | 98,019 | 0 | 0 | Mixed |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Combines 16 wordings of this item as funds reported it.
93% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.
VIKING THERAPEUTICS INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 63,234,707 for, 4,510,461 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,331 | 245 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 0 | 769,898 | 0 | 0 | Against |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 316,600 | 0 | 0 | Against |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 266,975 | 0 | 0 | Against |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Fund voting reports, all 105 managers: 33,697,793 for, 1,972,972 against, 18,525 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,346,837 | 0 | 0 | 0 | For |
| State Street | 3,005,218 | 326 | 0 | 0 | For |
| BlackRock | 2,750,147 | 14,865 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,841,944 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,439,494 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,234,936 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 1,094,940 | 0 | 0 | 0 | For |
| Charles Schwab | 855,375 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 818,055 | 0 | 0 | 0 | For |
| American Century | 0 | 759,217 | 0 | 0 | Against |
| JPMorgan | 754,651 | 0 | 0 | 0 | For |
| Voya | 740,991 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 673,864 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 596,976 | 0 | 0 | 0 | For |
| Northern Trust | 569,391 | 73 | 0 | 0 | For |
| Citadel | 563,735 | 0 | 0 | 0 | For |
| BAMCO INC /NY/ | 0 | 480,173 | 0 | 0 | Against |
| BRAIDWELL LP | 470,839 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 463,501 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 441,228 | 21,987 | 0 | 0 | For |
| Nuveen | 454,773 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 446,776 | 0 | 0 | 0 | For |
| Artia Global Partners LP | 432,129 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 11,414 | 416,227 | 0 | 0 | Against |
| Invesco | 420,879 | 0 | 0 | 0 | For |
Institutional-manager reports, all 294 managers: 45,029,875 for, 3,078,995 against, 150 withheld, 808 abstained, 56 not voted. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.1% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE SELECTION OF MARCUM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024.
VIKING THERAPEUTICS INC.’s own tally for this item (“2. To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024”): 87,382,144 for, 743,579 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of VIKING THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 108 asset managers below reported 35,779,182 for, 164 against, 18,525 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,412 | 164 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of May 20, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 110,228,869 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.04% |
| 2 | Vanguard | 6.99% |
| 3 | BlackRock | 3.27% |
| 4 | State Street | 0.95% |
| 5 | Charles Schwab | 0.76% |
| 6 | American Century | 0.70% |
| 7 | Voya | 0.55% |
| 8 | JPMorgan | 0.52% |
| 9 | AllianceBernstein | 0.52% |
| 10 | TIAA | 0.37% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.83% |
| 2 | State Street | 2.73% |
| 3 | BlackRock | 2.51% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.67% |
| 5 | AllianceBernstein | 1.31% |
| 6 | PICTET ASSET MANAGEMENT SA | 1.12% |
| 7 | VIKING GLOBAL INVESTORS LP | 0.99% |
| 8 | Charles Schwab | 0.78% |
| 9 | PNC BANK, NATIONAL ASSOCIATION | 0.74% |
| 10 | American Century | 0.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 13.61% | DEF14A |
| Vanguard Group | 9.07% | 13F |
| FMR (Fidelity) | 5.25% | 13F |
| BlackRock | 5.08% | 13F |
| Entities Associated with Viking Global Investors LP | 4.67% | DEF14A |
| Morgan Stanley | 3.38% | 13F |
| Brian Lian, Ph.D. | 3.09% | DEF14A |
| State Street | 3.02% | 13F |
| Citadel Advisors | 2.83% | 13F |
| JPMorgan Chase | 2.34% | 13F |
Percentages above are of 110,228,869 shares outstanding, as reported by VIKING THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VIKING THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At VIKING THERAPEUTICS INC.'s shareholder meeting held May 21, 2024, in the 2023-2024 proxy season, 372 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,502 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — VIKING THERAPEUTICS INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VIKING THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2024.
VIKING THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.